Pharmaceutical Research and Manufacturers of America
Tracked across 4 events · 51 articles · First seen May 11, 2025 · Last active Jun 30, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Impact: Pharmaceutical Research and Manufacturers of America criticized the new pharmaceutical tariffs, warning they would increase healthcare costs and jeopardize U.S. investments.
Apr 02, 2026 · 23 articles
Domestic
Impact: Pharmaceutical Research and Manufacturers of America, a trade association for pharmaceutical companies, states that pharmacy benefit managers and insurers create access and affordability barriers for patients.
Apr 02, 2026 · 6 articles
Domestic
Impact: Pharmaceutical Research and Manufacturers of America, a pharmaceutical company trade group, warned that Donald Trump's proposed tariffs on cutting-edge medicines could increase costs and jeopardize billions in U.S. investments.
Apr 02, 2026 · 16 articles
Regulatory
Impact: Pharmaceutical Research and Manufacturers of America (PhRMA) believes the CMS programs would be illegal and is challenging them.
Apr 20, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Pharmaceutical Research and Manufacturers of America live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard